Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Baldo

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|March 25, 2022
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical PracticeSabrina Orzetti, Federica Tommasi, Antonella Bertola, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Interferon-alpha for maintenance of follicular lymphomaPaolo Baldo, Maurizio Rupolo, Anna Compagnoni, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid CancerEmanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, et al.
Recenti Progressi in Medicina|November 1, 2022
[Application of artificial intelligence for an early comparison of efficacy between new cancer drugs.]Vera Damuzzo, Melania Rivano, Paolo Baldo, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active PharmacovigilanceAnna Parzianello, Giulia Fornasier, Valentina Kiren, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 17, 2015
Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education InitiativesIvana Truccolo, Chiara Cipolat Mis, Silvia Cervo, et al.
Frontiers in Immunology|July 11, 2025
The influence of <i>H. pylori</i> infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathwayValli De Re, Mariateresa Casarotto, Giulia Brisotto, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial CancerRiccardo Vida, Michele Bartoletti, Lucia Lerda, et al.
Frontiers in Oncology|April 11, 2024
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)Alessandro Cafaro, Flavia Foca, Oriana Nanni, et al.
Journal of Xenobiotics|January 21, 2026
Cross-Sectional Multicenter Biomonitoring Study on Genotoxicity and Oxidative DNA Damage in Oncology Healthcare Workers from Seven Italian HospitalsCinzia Lucia Ursini, Giorgia Di Gennaro, Giuliana Buresti, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|March 25, 2022
Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical PracticeSabrina Orzetti, Federica Tommasi, Antonella Bertola, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Interferon-alpha for maintenance of follicular lymphomaPaolo Baldo, Maurizio Rupolo, Anna Compagnoni, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid CancerEmanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, et al.
Recenti Progressi in Medicina|November 1, 2022
[Application of artificial intelligence for an early comparison of efficacy between new cancer drugs.]Vera Damuzzo, Melania Rivano, Paolo Baldo, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active PharmacovigilanceAnna Parzianello, Giulia Fornasier, Valentina Kiren, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 17, 2015
Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education InitiativesIvana Truccolo, Chiara Cipolat Mis, Silvia Cervo, et al.
Frontiers in Immunology|July 11, 2025
The influence of <i>H. pylori</i> infection in HER2-positive gastric cancer cell lines: insights from Wnt/β-catenin pathwayValli De Re, Mariateresa Casarotto, Giulia Brisotto, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial CancerRiccardo Vida, Michele Bartoletti, Lucia Lerda, et al.
Frontiers in Oncology|April 11, 2024
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)Alessandro Cafaro, Flavia Foca, Oriana Nanni, et al.
Journal of Xenobiotics|January 21, 2026
Cross-Sectional Multicenter Biomonitoring Study on Genotoxicity and Oxidative DNA Damage in Oncology Healthcare Workers from Seven Italian HospitalsCinzia Lucia Ursini, Giorgia Di Gennaro, Giuliana Buresti, et al.
Pageof 4